News | Cardiac Resynchronization Therapy Devices (CRT) | October 27, 2021

Leadless CRT Can Deliver Left Bundle Branch Area Pacing for Cardiac Resynchronization

EBR Systems WiSE CRT device shows wireless pacing could be used as a first-line therapy for patients


October 27, 2021 ​​— EBR Systems Inc., developer of the world’s first wireless cardiac pacing system for heart failure, announced the publication of a case report demonstrating its WiSE cardiac resynchonization therapy (CRT) system’s ability to successfully deliver leadless left bundle branch area pacing (LBBAP). 

WiSE is the only leadless pacing technology able to achieve LBBAP, a novel form of conduction system pacing which can reverse left bundle branch block and deliver cardiac resynchronization therapy (CRT).

Published last month in the European Heart Journal, the case report details the successful deployment of the WiSE Electrode implanted in the LV septum of an 82-year-old male with tachyarrhythmia-induced cardiomyopathy.[1] The patient exhibited improved electrical resynchronization on ECG and reported significant symptomatic improvement at six-month follow-up. This is the first reported case of LBBAP delivered via the WiSE CRT system, and it is also the first reported case of permanent LBBAP from the LV aspect of the interventricular septum.

“We are pleased to confirm WiSE’s ability to deliver leadless left bundle branch pacing in this new report,” said Professor Pascal Defaye, the head of rhythmology and cardiac stimulation unit at CHU de Grenoble-Alpes, France, who performed the implant. “WiSE is the first and only leadless pacing system that can deliver physiologic, conduction system pacing without leads. Our initial case demonstrates the exciting potential of EBR’s technology.”

LBBAP pacing has been proposed as a strategy to achieve physiological pacing by utilizing the heart’s native conduction system, allowing faster left ventricular activation time[2]. LBBAP has potential applications in both traditional bradycardia pacing and as an alternative approach to Cardiac Resynchronization Therapy (CRT)[3]. Until now, LBBAP has required use of a conventional pacing lead, driven deep into the ventricular septum, which can be technically challenging[4].

“EBR continues to pursue the feasibility of leadless LBBAP and the hope that the WiSE CRT system can benefit even more patients,” said John McCutcheon, president and CEO at EBR Systems. “We are committed to supporting an upcoming physician-initiated study to further investigate WiSE’s potential to deliver first-line therapy for patients.” 
     

Leadless CRT Pacing Technology

EBR Systems’ WiSE is the world’s only wireless, endocardial (inside the heart) pacing system in clinical use for stimulating the heart’s left ventricle. This has long been a goal of cardiac pacing companies since internal stimulation of the left ventricle is thought to be a potentially superior, more anatomically correct pacing location. WiSE Technology enables cardiac pacing of the left ventricle with a novel cardiac implant that is roughly the size of a large grain of rice. The need for a pacing wire on the outside of the heart’s left ventricle – and the attendant problems – are potentially eliminated.

WiSE is an investigational device and is not currently available for sale in the United States.

 

Related Leadless CRT Content:

VIDEO: How to Implant a Leadless CRT LV Pacing System

Leadless Endocardial CRT Pacing Effective for Heart Failure Patients

What is New in Electrophysiology Technologies

Leadless Pacemaker Stimulates Heart With Wireless Transmission of Energy

 

References: 

1. Mark K Elliott, Peggy Jacon, Baldeep Singh Sidhu, et al. Technical feasibility of leadless left bundle branch area pacing for cardiac resynchronisation: A case series. European Heart Journal - Case Reports. Published 24 September 2021. ytab379, https://doi.org/10.1093/ehjcr/ytab379.

2. Zhang W, Huang J, Qi Y, et al. Cardiac Resynchronization Therapy by Left Bundle Branch Area Pacing in Patients with Heart Failure and Left Bundle Branch Block. Heart Rhythm. 2019; 16(12):1783-1790.

3. Padala SK and Ellenbogen KA. Left Bundle Branch Pacing is the Best Approach to Physiological Pacing. Heart Rhythm O2. 2020; 1(1):59-67.

4. Li X, Li H, Ma W, et al. Permanent Left Bundle Branch Area Pacing for Atrioventricular Block: Feasibility, Safety, and Acute Effect. Heart Rhythm. 2019;16:1766-1773.


Related Content

News | Heart Failure

September 19, 2022 — A first-in-human (FIH) study using the ModulHeart device (Puzzle Medical Devices Inc.) has ...

Home September 19, 2022
Home
News | Heart Failure

September 15, 2022 — Today, aortic stenosis (AS) is one of the most common and serious valve disease problems [1]. It ...

Home September 15, 2022
Home
News | Heart Failure

September 14, 2022 — Minimally invasive, catheter-based transcatheter aortic valve replacement (TAVR) has revolutionized ...

Home September 14, 2022
Home
News | Heart Failure

September 2, 2022 — Dapagliflozin reduces the risk of cardiovascular death or worsening heart failure in heart failure ...

Home September 02, 2022
Home
News | Heart Failure

September 2, 2022 — Acetazolamide added to intravenous loop diuretics decreases congestion within three days in patients ...

Home September 02, 2022
Home
News | Heart Failure

September 2, 2022 — Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure ...

Home September 02, 2022
Home
News | Heart Failure

August 29, 2022 — Detailed results from the DELIVER Phase III trial showed AstraZeneca’s FARXIGA (dapagliflozin) ...

Home August 29, 2022
Home
News | Heart Failure

August 24, 2022 — Patients diagnosed with moderate aortic stenosis and congestive heart failure may qualify to ...

Home August 24, 2022
Home
News | Heart Failure

August 19, 2022 — Hackensack Meridian Health, Hackensack University Medical Center cardiac surgeon Yuriy Dudiy, M.D ...

Home August 19, 2022
Home
News | Heart Failure

August 8, 2022 — A major risk factor for diabetes, insulin resistance occurs when the cells of the body do not respond ...

Home August 08, 2022
Home
Subscribe Now